BeStock  
Stocks › Biotechnology › WVE

Wave Life Sciences WVE

US equityMarket cap rank #3510Biotechnology
$3.54 +$0.02 (+0.57%)
Pre-market · Oct 8, 6:20 am ET · After hours $3.54 -0.06%
Open$3.48
Prev close$3.52
Day range$3.43 – $3.60
Volume3.05M
Market cap$697.55M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$2.27M-73.9% YoY
Operating profit-$73.80M-39.9% YoY
Net profit-$69.36M-37.4% YoY
Diluted EPS-$0.34-9.7% YoY
Free cash flow-$54.47M-17.6% YoY
Operating cash flow-$53.58M

Revenue, last 8 quarters

$-7.7MSep '24$83.7MDec '24$9.2MMar '25$8.7MJun '25$7.6MSep '25$17.2MDec '25$38.2MMar '26$2.3MJun '26

Net profit, last 8 quarters

$-61.8MSep '24$29.3MDec '24$-46.9MMar '25$-50.5MJun '25$-53.9MSep '25$-53.2MDec '25$-26.1MMar '26$-69.4MJun '26

Diluted EPS by quarter

-0.47Sep '240.17Dec '24-0.29Mar '25-0.31Jun '25-0.32Sep '25-0.30Dec '25-0.13Mar '26-0.34Jun '26

Free cash flow by quarter

$-46.9MSep '24$-43.7MDec '24$-63.2MMar '25$-46.3MJun '25$-44.9MSep '25$-33.8MDec '25$-60.0MMar '26$-54.5MJun '26

Annual revenue

$20.1MFY20$41.0MFY21$3.6MFY22$113.3MFY23$108.3MFY24$42.7MFY25

Profitability & balance sheet

Operating margin-333.4%
Net margin-309.7%
Return on equity-68.3%
Return on assets-50.0%
Return on invested capital-61.5%
Current ratio9.99
Liabilities / assets18.8%
Cash & investments$490.60M
Total debt$40.08M
Net cash (debt)$450.52M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $2.27M $38.25M $42.73M $17.25M $7.61M
Total Operating Revenue $2.27M $38.25M $42.73M $17.25M $7.61M
Operating Expense $76.07M $69.54M $258.11M $73.71M $63.96M
Selling and Admin Expenses $24.78M $22.10M $75.33M $20.90M $18.09M
-General & Admin Expense $24.78M $22.10M $75.33M $20.90M $18.09M
Research & Development $51.29M $47.44M $182.78M $52.81M $45.87M
Operating Profit -$73.80M -$31.30M -$215.38M -$56.47M -$56.35M
Net Non-Operating Interest Income (Expense) $4.72M $5.29M – – $2.18M
Non-Operating Interest Income $4.72M $5.29M – – $2.18M
Other Income (Expense) -$275,000.00 -$80,000.00 $11.01M $10.71M $324,000.00
Other Non-Operating Income (Expenses) -$275,000.00 -$80,000.00 $527,000.00 $234,000.00 $324,000.00
Pretax Profit -$69.36M -$26.09M -$204.38M -$53.18M -$53.85M
Tax $0.00 $0.00 $0.00 $0.00 $0.00
Net Profit -$69.36M -$26.09M -$204.38M -$53.18M -$53.85M
Profit from Continuing Operations -$69.36M -$26.09M -$204.38M -$53.18M -$53.85M
Net Income to Parent Company -$69.36M -$26.09M -$204.38M -$53.18M -$53.85M
Net Income to Common Stockholders -$69.36M -$26.09M -$204.38M -$53.18M -$53.85M
Basic EPS -$0.34 -$0.13 -$1.21 -$0.30 -$0.32
Diluted EPS -$0.34 -$0.13 -$1.21 -$0.30 -$0.32
Gain on Sale of Security – – $10.48M – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $558.32M $583.54M $638.50M $638.50M $241.38M
Total Current Assets $507.51M $561.27M $614.81M $614.81M $215.49M
Cash and Cash Equivalents & Short-Term Investments $490.60M $544.59M $602.07M $602.07M $196.22M
-Cash and Cash Equivalents $368.01M $544.59M $602.07M $602.07M $196.22M
-Short Term Investments $122.59M – – – –
Receivables $888,000.00 $0.00 $1.28M $1.28M $10.00M
-Accounts Receivable $888,000.00 $0.00 $1.28M $1.28M $10.00M
Prepaid Assets $12.12M $13.23M $8.40M $8.40M $6.65M
Other Current Assets $3.90M $3.46M $3.08M $3.08M $2.62M
Total Non-Current Assets $50.81M $22.27M $23.69M $23.69M $25.89M
Net PPE $46.33M $18.07M $19.86M $19.86M $22.07M
-Gross PPE $97.15M $68.42M $69.39M $69.39M $70.83M
-Accumulated Depreciation -$50.82M -$50.35M -$49.52M -$49.52M -$48.76M
Other Non-Current Assets $4.48M $4.20M $3.82M $3.82M $3.82M
Total Liabilities $104.80M $71.81M $120.14M $120.14M $116.83M
Total Current Liabilities $50.82M $49.83M $95.07M $95.07M $85.90M
Payables $20.36M $19.06M $15.70M $15.70M $14.49M
-Accounts Payable $20.36M $19.06M $15.70M $15.70M $14.49M
Current Accrued Expenses $7.87M $7.52M $8.48M $8.48M $5.35M
Short-Term Debt and Capital Lease Obligation $3.51M $8.33M $8.36M $8.36M $8.39M
-Current Capital Lease Obligation $3.51M $8.33M $8.36M $8.36M $8.39M
Current Deferred Liabilities $8.70M $9.40M $44.44M $44.44M $46.53M
Total Non-Current Liabilities $53.99M $21.98M $25.08M $25.08M $30.93M
Long Term Debt and Capital Lease Obligation $40.08M $7.39M $9.41M $9.41M $11.38M
-Long Term Capital Lease Obligation $40.08M $7.39M $9.41M $9.41M $11.38M
Non-Current Deferred Liabilities $13.90M $14.60M $7.80M $7.80M $11.68M
Convertible preferred securities $0.00 $0.00 $7.87M $7.87M $7.87M
Total Equity $453.52M $511.73M $518.36M $518.36M $124.55M
Stockholders' Equity $453.52M $511.73M $518.36M $518.36M $124.55M
Capital Stock $1.63B $1.63B $1.62B $1.62B $1.22B
-Common Stock $1.63B $1.63B $1.62B $1.62B $1.22B
Additional Paid-In Capital $248.16M $237.43M $228.37M $228.37M $174.08M
Retained Earnings -$1.42B -$1.35B -$1.33B -$1.33B -$1.27B
Gains/Losses Not Affecting Retained Earnings -$172,000.00 -$254,000.00 -$250,000.00 -$250,000.00 -$190,000.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$53.58M -$59.55M -$187.49M -$33.78M -$44.67M
Net cash flow from continuing operations -$53.58M -$59.55M -$187.49M -$33.78M -$44.67M
Net Income from Continuing Operations -$69.36M -$26.09M -$204.38M -$53.18M -$53.85M
Depreciation & Depletion & Amortization $2.37M $2.31M $8.85M $2.26M $2.23M
Change in Working Capital $2.74M -$44.83M -$16.94M $9.79M $484,000.00
-Change in Receivables -$888,000.00 $1.28M $146,000.00 $8.72M -$8.38M
-Change in Prepaid Assets $1.10M -$4.83M $1.15M -$1.74M $47,000.00
-Change in Payables and Accrued Expense $6.77M -$10.23M $4.92M $11.23M $3.52M
-Change in Other Current Assets -$722,000.00 -$751,000.00 $4.31M -$452,000.00 $4.85M
-Change in Other Current Liabilities -$2.14M -$2.05M -$7.64M -$2.01M -$1.94M
-Change In Other Working Capital -$1.39M -$28.25M -$19.83M -$5.97M $2.39M
Net cash flow from investing -$123.45M -$438,000.00 -$718,000.00 $1,000.00 -$248,000.00
Net Cash Flow from Continuing Investing Activities -$123.45M -$438,000.00 -$718,000.00 $1,000.00 -$248,000.00
Net PPE Purchase and Sale -$884,000.00 -$438,000.00 -$718,000.00 $1,000.00 -$248,000.00
Financing Cash Flow $330,000.00 $2.53M $488.24M $439.70M $32.69M
Net Cash Flow from Continuing Financing Activities $330,000.00 $2.53M $488.24M $439.70M $32.69M
Net Common Stock Issuance $0.00 $0.00 $472.49M $429.91M $30.21M
Proceeds from Stock Option Exercised $330,000.00 $2.53M $15.75M $9.78M $2.48M
Ending Cash Balance $371.82M $548.41M $605.87M $605.87M $200.01M
Net Change in Cash -$176.71M -$57.46M $300.02M $405.92M -$12.22M
Beginning Cash Balance $548.41M $605.87M $305.84M $200.01M $212.27M
Effect of Exchange Rate Changes $123,000.00 -$4,000.00 $12,000.00 -$60,000.00 -$29,000.00
Free Cash Flow -$54.47M -$59.99M -$188.21M -$33.78M -$44.91M

Discussion

No comments yet — be the first to weigh in on WVE.

Leave a comment

Scroll to Top